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Background: The importance of non-glucose carbohydrates, especially mannose and inositol, for normal development
is increasingly recognized. Whether pregnancies complicated by abnormal glucose transfer to the fetus also affect
the regulation of non-glucose carbohydrates is unknown. In pregnant sheep, maternal insulin infusions were used
to reduce glucose supply to the fetus for both short (2-wk) and long (8-wk) durations to test the hypothesis that a
maternal insulin infusion would suppress fetal mannose and inositol concentrations. We also used direct fetal insulin
infusions (1-wk hyperinsulinemic-isoglycemic clamp) to determine the relative importance of fetal glucose and insulin
for regulating non-glucose carbohydrates.
Results: A maternal insulin infusion resulted in lower maternal (50%, P < 0.01) and fetal (35-45%, P < 0.01) mannose
concentrations, which were highly correlated (r2 = 0.69, P < 0.01). A fetal insulin infusion resulted in a 50% reduction of
fetal mannose (P < 0.05). Neither maternal nor fetal plasma inositol changed with exogenous insulin infusions.
Additionally, maternal insulin infusion resulted in lower fetal sorbitol and fructose (P < 0.01).
Conclusions: Chronically decreased glucose supply to the fetus as well as fetal hyperinsulinemia both reduce fetal
non-glucose carbohydrates. Given the role of these carbohydrates in protein glycosylation and lipid production, more
research on their metabolism in pregnancies complicated by abnormal glucose metabolism is clearly warranted.
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The importance of non glucose carbohydrates for nor-
mal fetal and neonatal development is becoming increas-
ingly recognized, especially for mannose and inositol
[1-4]. Carbohydrates not only serve as substrates for the
glycolytic pathway, but also are critical for glycoprotein
formation [5], phospholipid and glycerol production
[2,6], and neural development [7,8]. Insights into fetal
metabolism of mannose and inositol have been provided
by recent reports which show that, like glucose, the fetus
is dependent on its mannose supply from the mother.
Conversely, the fetus and placenta endogenously pro-
duce inositol from glucose [9,10]. In the term neonate,* Correspondence: Laura.Brown@ucdenver.edu
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unless otherwise stated.the utilization rates of mannose and inositol are much
higher than the rate which could be obtained from
human milk, suggesting endogenous production of both
substrates after birth to meet daily requirements [11,12].
Pathological conditions in pregnancy such maternal
under nutrition, placental insufficiency, and diabetes
have the potential to increase or decrease the delivery of
carbohydrates to the fetus and adversely affect growth,
body composition, and long term outcomes in human
and livestock pregnancy [13,14]. For example, diabetic
pregnancies are characterized by increased glucose
transfer to the fetus with subsequent elevations in fetal
insulin concentrations [15]. In adults, insulin regulates
mannose concentrations independent of glucose by
suppression of hepatic mannose production [16-19]. Thus,
the fetus is potentially at risk for hypomannosemia, both
from fetal hyperinsulinemia as well as from decreased
mannose delivery from the mother if insulin is used
to manage maternal diabetes. Placental insufficiency inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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delivery to the fetus leading to decreased fetal glucose
and insulin concentrations [20,21]. Placental insuffi-
ciency in pregnant sheep also decreases fetal sorbitol
and inositol concentrations [22]. Thus, a better under-
standing of the metabolism of non glucose carbohy-
drates during pregnancy is warranted, especially when
carbohydrate supply to the fetus is compromised.
We experimentally decreased maternal glucose con-
centrations in sheep pregnancies using an insulin infu-
sion both short term (2-wk) and long term (8-wk) to test
the hypothesis that a maternal insulin infusion would
suppress maternal and thus fetal mannose and inositol
concentrations. We also used direct fetal insulin infusions
in the form of a 1-wk hyperinsulinemic-isoglycemic clamp
to determine the relative importance of fetal glucose and
insulin concentrations for regulating fetal non glucose
carbohydrates. Finally, we report for the first time the
concentrations of several other carbohydrates and poly-
ols under each of these conditions.
Methods
Surgical preparation
Three separate groups of Columbia-Rambouillet ewes
with singleton pregnancies were used for the following
experiments: 1) 2-wk maternal insulin infusion, 2) 8-wk
maternal insulin infusion, and 3) 1-wk direct fetal insulin
infusion. All maternal and fetal surgical preparations
and post operative care have been previously described
[23-25]. Maternal femoral venous and arterial catheters
were placed through a left groin incision. Fetal infusion
catheters were placed into fetal femoral veins via hind
limb pedal veins and sampling catheters were placed into
the fetal abdominal aorta via a hind limb pedal artery.
Ewes were fed Premium Alfalfa Pellets (Standlee; Kimberly
ID) and intake was not different between control and
hypoglycemic groups (1.80 ± 0.10 kg/d control; 1.59 ±
0.10 kg/d hypoglycemic).
Care and use of animals
All animal procedures have followed established stan-
dards for the humane care and use of animals and were
in compliance with guidelines of the United States
Department of Agriculture, the National Institutes of
Health, and the American Association for the Accredit-
ation of Laboratory Animal Care. The animal care and use
protocols were approved by the University of Colorado
Institutional Animal Care and Use Committee.
Experimental design
Two-Wk maternal insulin infusion
For the 2-wk maternal insulin infusion group and their
respective controls, maternal and fetal catheters were
surgically placed at 122.8 ± 1.3 d of gestation (dGA;term = 148 dGA) [23,26-28]. One randomly assigned
group received a continuous maternal infusion of intra-
venous insulin for 2-wk. Maternal arterial plasma glu-
cose was measured at least twice daily and the insulin
infusion was adjusted to achieve a 40-50% reduction in
glucose concentrations (2-wk HG; n = 8). Maternal in-
sulin concentrations are approximately doubled by this
experimental design [29]. The control group received a
maternal saline infusion at rates matched to the insulin
infusion rates (2-wk C; n = 13). Fetal arterial plasma
was sampled at the end of the 2-wk maternal infusion
period for insulin and carbohydrate measurements.
Eight-Wk maternal insulin infusion
For the 8-wk maternal insulin group and their respective
controls, an initial surgery was performed at 70.0 ± 0.8
dGA to place maternal catheters [25]. One randomly
assigned group (n = 9) received a continuous maternal
infusion of intravenous insulin for 8-wk. Maternal arter-
ial plasma glucose was measured at least twice daily and
the insulin infusion was adjusted to achieve a 40-50%
reduction in glucose concentrations. Maternal insulin
concentrations are approximately doubled by this ex-
perimental design [30,31]. The control group received a
maternal saline infusion at rates matched to the insulin
infusion rates (8-wk C; n = 5). At 119.4 ± 0.5 dGA, a second
surgery was performed to place fetal catheters. After the
second surgery, 8-wk HG ewes were further randomly
divided into 2 groups. Fetuses in one of these groups
received a direct fetal insulin infusion for the final week of
the study (8-wk HG+I; n = 4). The insulin infusion was
kept constant at 100 mU/h (using necropsy weights =
38.9 mU/kg/h ± 2.8) and ran concurrently with a direct
fetal infusion of 33% dextrose (wt/vol) to prevent a fur-
ther fall in fetal glucose concentrations. Fetal arterial
plasma glucose concentrations were measured at least
twice daily and the dextrose infusion was adjusted
accordingly. The other group received a direct fetal saline
infusion matched at equal infusion rates to the combined
insulin and dextrose infusion (8-wk HG; n = 5). Finally,
fetuses in the 8-wk C group also received a direct fetal
saline infusion at equal rates. Fetal arterial plasma was
sampled at the end of the infusions for insulin and carbo-
hydrate measurements.
One-Wk fetal insulin infusion
Six late gestation animals were used in this experiment.
Fetal catheters were placed at 118.5 ± 0.6 dGA. All
fetuses received an insulin infusion with a concurrent dex-
trose infusion into a fetal hind limb vein. The insulin infu-
sion rate was progressively increased such that infusion rates
ranged from 36.6 ± 8.4 mU/h on the first day to 121.8 ±
1.2 mU/h on the final d. The fetal dextrose infusion was
adjusted to prevent a fall in glucose concentrations based
Table 1 Two-Wk maternal insulin infusion
Measurement Control Hypoglycemic
Gestational age, d 138.5 ± 0.4 137.5 ± 0.8
Fetal weight, kg 4.37 ± 0.14 3.30 ± 0.18**
Fetal plasma arterial insulin, ng/mL 0.30 ± 0.03 0.11 ± 0.01**
Fetal plasma arterial carbohydrates, μmol/L
Glucose 1,159 ± 64 594 ± 47**
Mannose 24.5 ± 1.2 15.9 ± 1.4**
Inositol 638.5 ± 138.6 1,129.0 ± 256.1
Sorbitol 123.8 ± 12.7 53.9 ± 10.5**
Fructose 4771 ± 450 1,909 ± 356**
Erythritol 399.6 ± 28.1 345.9 ± 20.8
Arabinol 245.0 ± 11.9 225.3 ± 15.6
Ribitol 128.1 ± 9.1 148.5 ± 18.8
Mannitol 72.8 ± 9.7 49.8 ± 10.1
Values are means ± SEM. ** refer to significant differences between Control (n = 13)
and Hypoglycemic (n = 8); P< 0.01 by Students t test or the Mann–Whitney test.
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twice daily. Baseline, 4d, and 7d fetal arterial plasma was
sampled for insulin and carbohydrate measurements.
Biochemical analysis
Whole blood was collected in EDTA-coated syringes
and immediately centrifuged (14,000 g) for 3 min at 4°C.
Plasma was removed and the glucose concentration
immediately determined using the YSI model 2700
select biochemistry analyzer (Yellow Springs Instru-
ments, Yellow Springs, OH) [23]. The remainder of the
plasma was stored at −70°C for insulin and carbohy-
drate measurements. Insulin (Alpco; inter-assay and
intra-assay coefficients of variation: 2.9 and 5.6%) was
measured by enzyme-linked immunosorbent assay
[23]. Plasma was analyzed for mannose, inositol, fruc-
tose, mannitol, erythritol, arabinol, sorbitol and ribitol
by HPLC as we have previously described [9].
Postmortem exam
Liver tissue from the right hepatic lobe was obtained in
the 8-wk HG, 8-wk C, and 8-wk HG+I fetuses under
conditions closely approximating in vivo study condi-
tions as previously described for measurement of sorb-
itol and fructose [25].
Statistical analysis
Statistical analysis was performed with SAS v.9.2 (SAS
Institute) and GraphPad Prism 4. Results are expressed
as mean ± SEM. P-values less than 0.05 were considered
significant. The 2-wk HG and C fetuses were compared
with Student’s t test (parametric data) or the Mann–
Whitney test (non parametric data). The 8-wk HG, HG+I,
and C fetuses were compared with a one-way ANOVA.
For measurements taken at multiple time points within an
animal a mixed models ANOVA was used with terms
for experimental group, time, group by time interaction
as indicated. Repeated measurements made within an
animal were accounted for. Post-test comparisons were
made using Fishers least squares difference if the overall
ANOVA had a P < 0.05.
Results
Two-Wk maternal insulin infusion
Fetal insulin, carbohydrates, and polyols
As previously reported [23,26-28], gestational ages were
similar, but fetal weight, fetal arterial plasma insulin, and
glucose were 24%, 63%, and 49% lower, respectively in the
2 wk HG group (P < 0.01, Table 1). We found lower fetal
arterial plasma concentrations of mannose (35%, P < 0.01),
sorbitol (57%, P < 0.01), and fructose (60%, P < 0.01) in
the 2-wk HG group (Table 1). Although the mean arter-
ial plasma inositol concentration was nearly doubled
in the 2-wk HG fetuses this did not reach statisticalsignificance. Other fetal plasma carbohydrate concen-
trations were similar between 2-wk HG and C groups
(Table 1).Eight-Wk maternal insulin infusion
Maternal plasma carbohydrates and polyols
Since 2-wk maternal insulin infusion experiments focused
only on plasma carbohydrate changes in the fetal circula-
tion, we included maternal carbohydrate analysis with the
8-wk insulin infusion studies. Consistent with study
design, maternal arterial plasma glucose concentrations
in the 8-wk HG group were approximately 40% lower
compared to 8-wk C group throughout the insulin infu-
sion period as previously reported (Table 2, P < 0.01)
[25]. Maternal arterial plasma mannose concentrations
also were 48% lower in the 8 wk HG group (Table 2, P <
0.01), but maternal arterial plasma inositol, sorbitol,
erythritol, arabinol, and ribitol did not change (Table 2).Fetal insulin, carbohydrates, and polyols
As previously reported, gestational age at the time of study
was not different between the groups. Fetal weights were
40% lower in the 8-wk HG group compared to 8-wk C
(Table 2, P < 0.01) [25]. Fetal arterial plasma insulin and
glucose were lower in the 8-wk HG group (P < 0.05,
Table 2) [25]. Fetal arterial plasma mannose was 44%
lower (P < 0.01), as were sorbitol (71%, P < 0.01) and fruc-
tose (64%, P < 0.01, Table 2). Furthermore, the arterial
plasma maternal - fetal mannose difference also was lower
(P < 0.01, Figure 1A), and fetal and maternal arterial
plasma mannose concentrations were highly correlated
(Figure 1B). Fetal arterial plasma inositol, erythritol,
Table 2 Eight-Wk maternal insulin infusion
Measurement Control Hypoglycemic HG+I
Gestational age, d 133.2 ± 1.1 133.0 ± 1.3 134.5 ± 0.9
Maternal plasma arterial carbohydrates, μmol/L
Glucose 3,605 ± 203 1,715 ± 145** 1,817 ± 95**
Mannose 67.0 ± 4.3 34.7 ± 3.5** 31.4 ± 5.0**
Inositol 27.7 ± 4.4 34.9 ± 3.9 34.6 ± 3.1
Sorbitol 13.4 ± 3.4 18.8 ± 4.2 11.8 ± 1.3
Erythritol 52.8 ± 5.5 44.5 ± 3.1 39.6 ± 8.5
Arabinol 96.2 ± 13.3 125.6 ± 6.5 118.0 ± 23.3
Ribitol 25.6 ± 3.0 25.9 ± 3.2 16.1 ± 4.3
Fetal weight, kg 3.66 ± 0.12 2.20 ± 0.14** 2.61 ± 0.21**
Fetal plasma arterial insulin, ng/mL 0.46 ± 0.09 0.16 ± 0.03* 0.66 ± 0.17
Fetal plasma arterial carbohydrates, μmol/L
Glucose 1,553 ± 282 587 ± 56** 511 ± 37**
Mannose 30.4 ± 3.8 17.0 ± 1.1** 7.9 ± 0.9**
Inositol 741.4 ± 240.8 910.1 ± 157.5 792.2 ± 199.5
Sorbitol 188.5 ± 31.9 55.2 ± 11.9** 41.3 ± 8.3**
Fructose 4,508 ± 981 1,631 ± 301** 800 ± 154**
Erythritol 394.6 ± 30.7 372.2 ± 9.3 311.6 ± 24.6
Arabinol 235.3 ± 17.1 237.5 ± 15.1 214.9 ± 54.3
Ribitol 124.3 ± 15.9 139.6 ± 21.7 156.8 ± 57.6
Mannitol 47.4 ± 8.5 31.4 ± 6.1 33.8 ± 8.7
Fetal hepatic sorbitol and fructose, nmol/g
Sorbitol 589.0 ± 90.1 205.8 ± 42.1** 161.3 ± 56.0**
Fructose 1,679 ± 219 398 ± 119** 215 ± 95**
Values are means ± SEM. *, ** refer to significant differences from Control (n = 5) animals; P < 0.05, 0.01, respectively, by ANOVA.
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8-wk HG and C groups (Table 2).
A direct fetal insulin infusion for the final wk of the
8-wk maternal insulin infusion with a concurrent direct
fetal dextrose infusion to prevent a further fall in fetal
arterial plasma glucose was used to determine the effect
of fetal glucose and insulin concentrations on regulating
fetal non glucose carbohydrates. The direct fetal insulin
infusion with a concurrent dextrose infusion (HG+I)
resulted in fetal arterial plasma insulin concentrations
3-fold higher than HG fetuses (P < 0.05) without a change
in fetal arterial plasma glucose concentrations (Table 2), as
previously reported [25]. HG+I fetuses demonstrated even
lower arterial plasma mannose concentrations when
compared to the HG group (53%, P < 0.05), and had
mean fructose concentrations which were over 50%
lower, though this failed to reach statistical significance
(P = 0.058 by post hoc Student’s t test). There was no
effect on fetal arterial plasma inositol, sorbitol, eryth-
ritol, arabinol, ribitol, and mannitol (Table 2). Fetal
hepatic sorbitol and fructose concentrations were lower inthe 8-wk HG group compared to C fetal livers (P < 0.01,
Table 2). HG+I fetuses did not have changes in hepatic
sorbitol or fructose compared to the 8-wk HG fetuses
(Table 2).
One-Wk fetal insulin infusion
In order to determine the effect of fetal glucose and
insulin concentrations for regulating non glucose car-
bohydrates in fetuses whose mothers did not receive a
chronic insulin infusion, we infused 6 fetuses directly
with insulin with a concurrent dextrose infusion to
maintain fetal glucose concentrations for 1 wk begin-
ning on 125.2 ± 0.7 dGA. Fetal plasma arterial glucose
concentrations were stable throughout the infusion
period, however the dextrose infusion was increased
progressively during the insulin infusion period to
maintain euglycemia, starting at 3.6 ± 1.1 mg/min and
ending at 12.1 ± 2.5 mg/min. Fetal arterial plasma insulin,
carbohydrate, and polyol concentrations were measured at
baseline and on d 4 and d 7 of the insulin infusion (Table 3).




































































Figure 1 Fetal and maternal mannose concentrations following
an eight wk maternal insulin infusion. A) The maternal-fetal arterial
plasma mannose difference measured in control (n = 5), hypoglycemic
(n = 5), and hypoglycemic + insulin (HG + I, n = 4).* indicates P < 0.05.
Values are mean ± SEM. B) In both control (black squares, n = 5) and
hypoglycemic fetal sheep (open circles, n = 5) fetal and maternal
arterial plasma mannose concentrations are highly correlated in control
(black squares) hypoglycemic animals (r2 = 0.69, P < 0.01).
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erythritol concentrations were decreased (P < 0.05).
Discussion
Non glucose carbohydrates are important for normal
fetal development [1-4]. Pathological conditions in preg-
nancy that adversely affect glucose delivery to the fetus
could affect the delivery of non glucose carbohydrates.
Therefore, the primary goal of the current study was to
determine how a maternal insulin infusion with an asso-
ciated reduction in glucose supply to the fetus affected
the plasma concentrations of these metabolites in both
the maternal and fetal circulations. We found that a
maternal insulin infusion which reduced glucose supply
to the fetus of both short (2-wk) and long (8-wk) dura-
tions resulted in decreased maternal and fetal mannoseconcentrations along with decreased fetal concentrations
of sorbitol and fructose. As in human pregnancies, fetal
and maternal arterial plasma mannose concentrations
were highly correlated, suggesting that maternal mannose
concentration determines fetal mannose concentrations.
However, a physiological increase in fetal insulin after pro-
longed fetal hypoglycemia further reduced circulating fetal
mannose concentrations, indicating that insulin also plays
a key role in regulating mannose concentrations. Finally,
we found that neither maternal nor fetal arterial plasma
inositol concentrations changed with exogenous insulin
infusions.
The most striking findings in this study relate to the
regulation of fetal mannose concentrations. There has
been emerging evidence in both normal human and
sheep pregnancies that the fetus is dependent on placental
delivery of mannose [9,10,32]. In fact, in human pregnan-
cies, it appears that over 95% of fetal circulating mannose
is derived from transplacental transfer from the mother
[10]. Our findings also support transplacental transfer of
mannose from the mother as the dominant source of cir-
culating fetal mannose, as we found that maternal and
fetal plasma arterial mannose concentrations were highly
correlated when an experimental maternal insulin infusion
decreased maternal mannose concentrations. Further-
more, we found a significant decrease in the maternal to
fetal mannose concentration difference in 8-wk HG sheep.
This finding suggests that decreased fetal mannose con-
centrations were due to decreased maternal mannose con-
centrations rather than a decrease in placental transport
capacity. In fact, when fetal and maternal mannose con-
centrations were measured in a sheep model of chronic
placental insufficiency there was a significant increase in
the maternal to fetal mannose concentration gradient,
indicating that placental insufficiency has the potential to
disrupt maternal to fetal mannose delivery [22].
Our results also demonstrate a key role for insulin in
the regulation of both maternal and fetal plasma man-
nose concentrations. We report for the first time that
long term (8-wk) maternal insulin infusion during
pregnancy results in a 50% reduction in maternal mannose
concentrations. As these maternal ewes were also chro-
nically hypoglycemic, we cannot determine whether
chronic hypoglycemia or chronic hyperinsulinemia was
directly responsible for reductions in mannose con-
centrations. However, previous work in rodents and
adults has shown that insulin is independently involved
in lowering plasma mannose by suppressing hepatic
glycogen breakdown and mannose efflux from the liver
[16,18]. In healthy adults, oral glucose administration
increased both glucose and insulin concentrations yet
mannose concentrations were still decreased, arguing
for insulin stimulated mannose disposal independent
of glucose [17,19].
Table 3 One-Wk fetal insulin infusion
Measurement d0 d4 d7
Fetal plasma arterial insulin, ng/mL 0.26 ± 0.03 0.92 ± 0.20** 0.92 ± 0.10**
Fetal plasma arterial carbohydrates, μmol/L
Glucose 1,338 ± 96 998 ± 76 1,201 ± 79
Mannose 33.9 ± 2.1 18.9 ± 2.4** 16.8 ± 2.1**
Inositol 838.2 ± 165.2 703.1 ± 144.3 673.3 ± 85.0
Sorbitol 163.4 ± 62.7 134.2 ± 76.1 82.5 ± 27.1
Fructose 5,751 ± 884 3,214 ± 673** 2,658 ± 538**
Erythritol 402.1 ± 38.2 356.5 ± 32.2* 330.3 ± 32.0**
Arabinol 193.9 ± 24.1 176.5 ± 28.4 178.3 ± 23.8
Ribitol 153.1 ± 21.4 148.9 ± 22.0 133.9 ± 17.1
Mannitol 69.4 ± 5.8 64.5 ± 10.0 60.1 ± 8.8
Values are means ± SEM. *, ** refer to significant differences from d0; P < 0.05, 0.01, respectively, by ANOVA. n = 6.
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some insight into the independent effects of glucose and
insulin on circulating mannose in the fetus. When a dir-
ect fetal insulin infusion restored physiological insulin
concentrations in 8-wk HG+I fetuses and fetal glucose
concentrations were maintained, fetal mannose concen-
trations were further reduced by 50%. This argues for
insulin mediated reductions in fetal plasma mannose to
extremely low concentrations (~8 μmol/L) independent
of concurrent hypoglycemia. To further determine the
independent effects of glucose and insulin on fetal man-
nose, we infused insulin with a concurrent dextrose
infusion to maintain glucose concentrations in a separ-
ate group of normal late gestation fetuses. This fetal
hyperinsulinemic-euglycemic clamp also resulted in
decreased mannose concentrations, confirming a role
for insulin in the regulation of fetal mannose independ-
ent of glucose concentrations.
We also showed decreased fetal arterial plasma sorb-
itol and fructose concentrations in 8-wk HG fetuses.
Contrary to our hypothesis, fetal plasma inositol concen-
trations were maintained during restricted fetal glucose
supply. Maternal glucose has several potential fates once
it enters the placenta. It can be directly transferred to
the fetus or oxidized for fuel production [10,33]. Add-
itionally, the placenta can convert glucose to inositol or
sorbitol [9,22,32]. Glucose is converted to inositol by
glucose-6-phosphate:1-phosphate cyclase and to sorbitol
by aldose reductase [34-36]. The balance between these
two pathways is regulated by NADPH derived from the
placental uptake of glutamate from the fetus [37-40].
Although we did not directly measure placental glutam-
ate uptake in this study, fetal arterial plasma glutamate
concentrations are reduced by 50% in HG fetuses, which
might lead to a reduction in placental NADPH availabil-
ity [41]. This would, in turn, limit placental production
of sorbitol and preserve or increase the production ofinositol. This also is consistent with our findings of
decreased fetal plasma fructose and decreased hepatic
sorbitol and fructose, as the major fate for fetal sorbitol
in the sheep is conversion to fructose in the liver by
sorbitol dehydrogenase.
Interestingly, fetal fructose concentrations also are
decreased by fetal insulin infusion independent of glucose.
Relationships between fructose and insulin have been
previously reported, such that pancreatectomized fetal
sheep have increased fructose concentrations [42], and
fructose infusion into the sheep fetus can stimulate
insulin secretion [43]. The role of fructose in human
fetal and neonatal development remains to be deter-
mined, though postulated roles include alternative path-
ways in glucose metabolism, redox balance, and lipid
synthesis [6,44].
The results of our study are limited only to changes in
maternal and fetal arterial plasma concentrations of
carbohydrates and polyols, thus conclusions cannot be
made regarding their uptake and utilization rates by the
fetus. However, the results are consistent with previous
studies in human fetuses showing placental transport of
maternal mannose, fetal production of inositol, and
placental export to the fetus of sorbitol [9,10]. Future stud-
ies are warranted to determine the effects of fetal glucose
and insulin on uptake, production, and utilization rates
of these carbohydrates, thus providing a more in depth
understanding of their metabolism in the pregnant mother
and fetus.
Conclusions
In summary, the results of this study show that a
chronic and constant maternal insulin infusion sup-
presses both maternal and fetal mannose concentra-
tions by approximately 50%. Additionally, insulin can
suppress fetal mannose and fructose concentrations inde-
pendent of glucose availability. The functional implications
Brown et al. Journal of Animal Science and Biotechnology 2014, 5:28 Page 7 of 8
http://www.jasbsci.com/content/5/1/28of this degree of fetal hypomannosemia are unclear, but a
recent report demonstrating embryonic lethality in mice
with a hypomorphic phosphomannomutase 2 gene defect
shows the critical role of mannose in normal fetal de-
velopment [4]. Our results also show a significant
reduction in fetal sorbitol concentrations, likely due to
decreased placental sorbitol production and transfer to
the fetus following increased shuttling of placental glucose
into inositol production. Taken together, our findings
demonstrate the potential for other carbohydrates, in
addition to glucose, to be adversely affected by alter-
ations in maternal and/or fetal insulin concentrations
and glucose supply. Given the important role that
many of these non glucose carbohydrates have in fetal
development, future research on pathological condi-
tions in pregnancy should include further investigation
into carbohydrate metabolism beyond glucose, espe-
cially when conditions of fetal hyperinsulinemia are
considered.
Abbreviations
dGA: Days gestational age; HG: Hypoglycemic; C: Control; HG+I: Iypoglycemic
plus insulin.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LDB and PJR conceived of the study, designed the study, acquired and
interpreted data, and wrote the first draft of the manuscript. ST conceived of
the study, acquired and interpreted data, and reviewed the manuscript. JL
acquired and interpreted data and reviewed the manuscript. AC designed
the study, acquired and interpreted data, and reviewed the manuscript. FB
conceived of the study, designed the study, interpreted data, and reviewed
the manuscript. All authors read and approved the final manuscript.
Acknowledgments
We thank Karen Trembler, David Caprio, and Gates Roe for their technical
support. JRL was supported by National Institutes of Health training grant
T32 HD007186-32 (W Hay, PI and PD). This work was supported by NIH Grants
R01DK088139 and K08HD060688, as well as American Diabetes Association
Junior Faculty Award 7-08-JF-51(PJR, PI). A Pilot and Feasibility Award to PJR
was provided by the UC Denver DERC (P30DK57516; J. Hutton, PI). LDB was
supported as a Scholar by NIH Building Interdisciplinary Careers in Women’s
Health Scholar Award K12HD057022 (J. Regensteiner, PI) and a Children’s
Hospital Colorado Research Institute Research Scholar Award (PI). SRT was
supported by NIH K01DK090199 (PI) and as a trainee on NIH training grant
T32 HD007186-32 (W Hay, PI and PD). The content is solely the responsibility of
the authors and does not necessarily represent the official views of the NIDDK
or NICHD.
Received: 4 March 2014 Accepted: 19 May 2014
Published: 22 May 2014
References
1. Groenen PM, Peer PG, Wevers RA, Swinkels DW, Franke B, Mariman EC,
Steegers-Theunissen RP: Maternal myo-inositol, glucose, and zinc status is
associated with the risk of offspring with spina bifida. Am J Obstet
Gynecol 2003, 189:1713–1719.
2. Hallman M, Saugstad OD, Porreco RP, Epstein BL, Gluck L: Role of myoinositol
in regulation of surfactant phospholipids in the newborn. Early Hum Dev
1985, 10:245–254.
3. Reece EA, Khandelwal M, Wu YK, Borenstein M: Dietary intake of myo-inositol
and neural tube defects in offspring of diabetic rats. Am J Obstet Gynecol
1997, 176:536–539.4. Schneider A, Thiel C, Rindermann J, DeRossi C, Popovici D, Hoffmann GF,
Grone HJ, Korner C: Successful prenatal mannose treatment for
congenital disorder of glycosylation-Ia in mice. Nat Med 2012, 18:71–73.
5. Davis JA, Freeze HH: Studies of mannose metabolism and effects of
long-term mannose ingestion in the mouse. Biochim Biophys Acta 2001,
1528:116–126.
6. Trindade CE, Barreiros RC, Kurokawa C, Bossolan G: Fructose in fetal cord
blood and its relationship with maternal and 48-hour-newborn blood
concentrations. Early Hum Dev 2011, 87:193–197.
7. Greene ND, Copp AJ: Mouse models of neural tube defects: investigating
preventive mechanisms. Am J Med Genet C: Semin Med Genet 2005,
135C:31–41.
8. Jaeken J, Matthijs G: Congenital disorders of glycosylation: a rapidly
expanding disease family. Annu Rev Genomics Hum Genet 2007, 8:261–278.
9. Brusati V, Jozwik M, Jozwik M, Teng C, Paolini C, Marconi AM, Battaglia
FC: Fetal and maternal non-glucose carbohydrates and polyols
concentrations in normal human pregnancies at term. Pediatr Res
2005, 58:700–704.
10. Staat BC, Galan HL, Harwood JE, Lee G, Marconi AM, Paolini CL, Cheung A,
Battaglia FC: Transplacental supply of mannose and inositol in
uncomplicated pregnancies using stable isotopes. J Clin Endocrinol Metab
2012, 97:2497–2502.
11. Cavalli C, Teng C, Battaglia FC, Bevilacqua G: Free sugar and sugar alcohol
concentrations in human breast milk. J Pediatr Gastroenterol Nutr 2006,
42:215–221.
12. Brown LD, Cheung A, Harwood JE, Battaglia FC: Inositol and mannose
utilization rates in term and late-preterm infants exceed nutritional
intakes. J Nutr 2009, 139:1648–1652.
13. De Blasio MJ, Gatford KL, McMillen IC, Robinson JS, Owens JA: Placental
restriction of fetal growth increases insulin action, growth, and adiposity
in the young lamb. Endocrinology 2007, 148:1350–1358.
14. Long NM, Tousley CB, Underwood KR, Paisley SI, Means WJ, Hess BW, Du M,
Ford SP: Effects of early- to mid-gestational undernutrition with or without
protein supplementation on offspring growth, carcass characteristics, and
adipocyte size in beef cattle. J Anim Sci 2012, 90:197–206.
15. Schwartz R, Gruppuso PA, Petzold K, Brambilla D, Hiilesmaa V, Teramo KA:
Hyperinsulinemia and macrosomia in the fetus of the diabetic mother.
Diabetes Care 1994, 17:640–648.
16. Sharma V, Freeze HH: Mannose efflux from the cells: a potential source of
mannose in blood. J Biol Chem 2011, 286:10193–10200.
17. Sone H, Shimano H, Ebinuma H, Takahashi A, Yano Y, Iida KT, Suzuki H,
Toyoshima H, Kawakami Y, Okuda Y, Noguchi Y, Ushizawa K, Saito K,
Yamada N: Physiological changes in circulating mannose levels in
normal, glucose-intolerant, and diabetic subjects. Metabolism 2003,
52:1019–1027.
18. Taguchi T, Yamashita E, Mizutani T, Nakajima H, Yabuuchi M, Asano N,
Miwa I: Hepatic glycogen breakdown is implicated in the maintenance
of plasma mannose concentration. Am J Physiol Endocrinol Metab 2005,
288:E534–E540.
19. Wood FC Jr, Cahill GF Jr: Mannose utilization in man. J Clin Invest 1963,
42:1300–1312.
20. Nicolini U, Hubinont C, Santolaya J, Fisk NM, Rodeck CH: Effects of fetal
intravenous glucose challenge in normal and growth retarded fetuses.
Horm Metab Res 1990, 22:426–430.
21. Limesand SW, Rozance PJ, Smith D, Hay WW Jr: Increased insulin
sensitivity and maintenance of glucose utilization rates in fetal sheep
with placental insufficiency and intrauterine growth restriction. Am J
Physiol Endocrinol Metab 2007, 293:E1716–E1725.
22. Regnault TR, Teng C, de Vrijer B, Galan HL, Wilkening RB, Battaglia FC:
The tissue and plasma concentration of polyols and sugars in sheep
intrauterine growth retardation. Exp Biol Med (Maywood) 2010,
235:999–1006.
23. Rozance PJ, Limesand SW, Hay WW Jr: Decreased nutrient-stimulated
insulin secretion in chronically hypoglycemic late-gestation fetal sheep
is due to an intrinsic islet defect. Am J Physiol Endocrinol Metab 2006,
291:E404–E411.
24. Maliszewski AM, Gadhia MM, O’Meara MC, Thorn SR, Rozance PJ, Brown LD:
Prolonged infusion of amino acids increases leucine oxidation in fetal
sheep. Am J Physiol Endocrinol Metab 2012, 302:E1483–E1492.
25. Thorn SR, Sekar SM, Lavezzi JR, O’Meara MC, Brown LD, Hay WW Jr, Rozance
PJ: A physiological increase in insulin suppresses gluconeogenic gene
Brown et al. Journal of Animal Science and Biotechnology 2014, 5:28 Page 8 of 8
http://www.jasbsci.com/content/5/1/28activation in fetal sheep with sustained hypoglycemia. Am J Physiol Regul
Integr Comp Physiol 2012, 303:R861–R869.
26. Limesand SW, Rozance PJ, Brown LD, Hay WW Jr: Effects of chronic
hypoglycemia and euglycemic correction on lysine metabolism in fetal
sheep. Am J Physiol Endocrinol Metab 2009, 296:E879–E887.
27. Rozance PJ, Limesand SW, Zerbe GO, Hay WW Jr: Chronic fetal
hypoglycemia inhibits the later steps of stimulus-secretion coupling in
pancreatic beta-cells. Am J Physiol Endocrinol Metab 2007, 292:E1256–E1264.
28. Thorn SR, Regnault TRH, Brown LD, Rozance PJ, Keng J, Roper M, Wilkening
RB, Hay WW Jr, Friedman JE: Intrauterine growth restriction increases fetal
hepatic gluconeogenic capacity and reduces messenger ribonucleic acid
translation initiation and nutrient sensing in fetal liver and skeletal
muscle. Endocrinology 2009, 150:3021–3030.
29. DiGiacomo JE, Hay WW Jr: Fetal glucose metabolism and oxygen
consumption during sustained hypoglycemia. Metabolism 1990,
39:193–202.
30. Carver TD, Hay WW Jr: Uteroplacental carbon substrate metabolism and
O2 consumption after long-term hypoglycemia in pregnant sheep. Am J
Physiol 1995, 269:E299–E308.
31. Carver TD, Quick AA, Teng CC, Pike AW, Fennessey PV, Hay WW Jr:
Leucine metabolism in chronically hypoglycemic hypoinsulinemic
growth-restricted fetal sheep. Am J Physiol Endocrinol Metab 1997, 272:
E107–E117.
32. Teng CC, Tjoa S, Fennessey PV, Wilkening RB, Battaglia FC: Transplacental
carbohydrate and sugar alcohol concentrations and their uptakes in
ovine pregnancy. Exp Biol Med (Maywood) 2002, 227:189–195.
33. Aldoretta PW, Hay WW Jr: Effect of glucose supply on ovine
uteroplacental glucose metabolism. Am J Physiol Regul Integr Comp Physiol
1999, 277:R947–R958.
34. Brachet EA: Presence of the complete sorbitol pathway in the human
normal umbilical cord tissue. Biol Neonate 1973, 23:314–323.
35. Mango D, Scirpa P, Menini E: Effects of dehydroepiandrosterone and 16
alpha-hydroxydehydroepiandrosterone on the reduction of glucose to
glucitol by the human placenta. Horm Metab Res 1976, 8:302–307.
36. Quirk JG Jr, Bleasdale JE: Myo-inositol homeostasis in the human fetus.
Obstet Gynecol 1983, 62:41–44.
37. Ginsburg J, Jeacock MK: Pathways of glucose metabolism in human
placental tissue. Biochim Biophys Acta 1964, 90:166–168.
38. Makarewicz W, Swierczynski J: Phosphate-dependent glutaminase in the
human term placental mitochondria. Biochem Med Metab Biol 1988,
39:273–278.
39. Moores RR Jr, Vaughn PR, Battaglia FC, Fennessey PV, Wilkening RB,
Meschia G: Glutamate metabolism in fetus and placenta of late-gestation
sheep. Am J Physiol 1994, 267:R89–R96.
40. Sakurai T, Takagi H, Hosoya N: Metabolic pathways of glucose in human
placenta. Changes with gestation and with added 17-beta-estradiol.
Am J Obstet Gynecol 1969, 105:1044–1054.
41. Limesand SW, Hay WW Jr: Adaptation of ovine fetal pancreatic insulin
secretion to chronic hypoglycaemia and euglycaemic correction. J Physiol
Lond 2003, 547:95–105.
42. Fowden AL, Comline RS: The effects of pancreatectomy on the sheep
fetus in utero. Q J Exp Physiol 1984, 69:319–330.
43. Philipps AF, Carson BS, Meschia G, Battaglia FC: Insulin secretion in fetal
and newborn sheep. Am J Physiol Endocrinol Metab 1978, 235:E467–E474.
44. Meznarich HK, Hay WW Jr, Sparks JW, Meschia G, Battaglia FC: Fructose
disposal and oxidation rates in the ovine fetus. Q J Exp Physiol 1987,
72:617–625.
doi:10.1186/2049-1891-5-28
Cite this article as: Brown et al.: Changes in fetal mannose and other
carbohydrates induced by a maternal insulin infusion in pregnant sheep.
Journal of Animal Science and Biotechnology 2014 5:28.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
